Overview
Updated 14 Jul 2026
Vance Garrison Fowler Jr., MD, is Florence McAlister Distinguished Professor of Medicine, Division of Infectious Diseases, Duke University School of Medicine. The public record shows 698 publications with 58,472 citations (h-index 114), centered on Antimicrobial Resistance in Staphylococcus, Infective Endocarditis Diagnosis and Management, Bacterial Identification and Susceptibility Testing. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 6 companies, 8 NIH-funded awards (1999–2026).
- Most recent indexed publication: 2026 · Science advances
- Top research focus: Antimicrobial Resistance in Staphylococcus
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 33 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 404.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae
Sponsor: Duke University
InvestigatorRecruitingNCT06815536 - Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial
Sponsor: Duke University
InvestigatorCompletedNCT06174649 - Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies
Sponsor: Duke University
InvestigatorCompletedNCT04710212
Industry payments
Updated 14 Jul 2026
6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- IntervascularProgram year20251 payment
- La Jolla Pharmaceutical CompanyProgram year20251 payment
NIH funding
Updated 14 Jul 2026
8 NIH research awards on record, funded 1999–2026 per NIH RePORTER. The latest:
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Reproducible Identification of Staphylococcus aureus Bacteremia Clinical Subphenotypes.
Clinical infectious diseases
2026 - Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections.
Clinical infectious diseases
2026 - Methicillin-resistant and susceptible Staphylococcus aureus: tolerance, immune evasion and treatment.
Nature reviews. Microbiology
2026
Most-cited worksby citation count (OpenAlex)
- 01
- 02
- 03
- 04
- 05Infective Endocarditis1,701 citations2005
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
Room 183, Hanes House, 315 Trent Drive, Durham, NC 27710
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →scholars.duke.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →scholars.duke.edu ↗
- Board Certified
Infectious Diseases, American Board of Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dukehealth.org ↗
Editorial & leadership rolesjournal and society appointments
- Contact Principal Investigator
NIH Antibacterial Resistance Leadership Group (ARLG), since inception in 2013
2013verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →arlg.org ↗ - Co-founder
International Collaboration on Endocarditis (ICE)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.duke.edu ↗ - Founder
Staphylococcus aureus Bacteremia Group (SABG) registry
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.duke.edu ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →arlg.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.duke.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.duke.edu ↗
Secondary affiliationsappointments beyond the home institution
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →newsinhealth.nih.gov ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →newsinhealth.nih.gov ↗
- "Meet the researcher: Vance Fowler, MD"
profile feature, Duke Department of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.duke.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/vance-fowler-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Vance-Fowler
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/vance-fowler-1435436
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by otherswhere others cite or feature them
- Other
arlg.org/vance-fowler-honored-with-distinguished-professorship-from-duke-school-of-medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →arlg.org ↗ - Apple Podcasts
podcasts.apple.com/us/podcast/ep-59-vance-fowler-the-antibacterial-resistance/id1441318864
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗ - LinkedIn
linkedin.com/in/samantha-keller-422770253
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Adrian Hernandez, MD
Duke University
- 1,590
- publications
- 134
- h-index
- 23
- trials
Jonathan Piccini, MD
Duke University
- 955
- publications
- 104
- h-index
- 7
- trials
Virginia Kraus, MD, PhD
Duke University
- 649
- publications
- 97
- h-index
- 4
- trials
Neal Ready, MD
Duke University
- 308
- publications
- 48
- h-index
- 12
- trials